Detection of hepatocellular carcinoma: Comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging

European Radiology

Volumn 15, Issue 5, 2005, Pages 895-903

  Simon, G ^a,b   Link, T M ^a,b   Wortler K ^a   Doebereiner, F ^a   Schulte Frohlinde, E ^a   Daldrup Link, H ^a,b   Settles, M ^a,b   Rummeny, E J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UCSF Hematology Oncology   (United States)

Author keywords

Contrast agents; Liver; Magnetic resonance imaging; Neoplasm

Indexed keywords

GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MCNEMAR TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; COMPARATIVE STUDY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 22844439885     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-005-2669-1     Document Type: Article

References (27)

1. Peterson M, Baron R, Murakami T (1996) Hepatic malignancies: Usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 201:337-345
2. Rode A, Bancel B, Douek P et al. (2001) Small nodule detection in cirrhotic livers: Evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25:327-336
3. Krinsky GA, Lee VS, Theise ND et al. (2001) Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: Prospective diagnosis with MR imaging and explantation correlation. Radiology 219:445-454 1:STN:280:DC%2BD3M3mt1eisg%3D%3D
4. Lim JH, Cho JM, Kim EY, Park CK (2000) Dysplastic nodules in liver cirrhosis: Evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 214:869-874
5. Krinsky GA, Theise ND, Rofsky NM, Mizrachi H, Tepperman LW, Weinreb JC (1998) Dysplastic nodules in cirrhotic liver: Arterial phase enhancement at CT and MR imaging - a case report. Radiology 209:461-464
6. Yu J-S, Kim KW, Jeong M-G, Lee JT, Yoo HS (2000) Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 217:750-756
7. Lim JH, Choi D, Cho SK et al. (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669-676
8. (1995) Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 22:983-993
9. Elizondo G, Weissleder R, Stark DD et al. (1990) Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 174:797-801 1:STN:280:By%2BC287htFE%3D
10. Lucidarme O, Baleston F, Cadi M et al. (2003) Non-invasive detection of liver fibrosis: Is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol 13:467-474. Epub 2002 Sep 13
11. Colombo M (1999) Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma. J Hepatol 31:25-30
12. Lencioni R, Pinto F, Armillotta N et al. (1997) Intrahepatic metastatic nodules of hepatocellular carcinoma detected at lipiodol-CT: imaging-pathologic correlation. Abdom Imaging 22:253-258
13. Pauleit D, Textor J, Bachmann R et al. (2002) Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 222:73-80 11756708
14. Tang Y, Yamashita Y, Arakawa A et al. (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: Comparison of gadolinium- and ferumoxides-enhanced MR imaging. Am J Roentgenol 172:1547-1554 1:STN:280:DyaK1M3nslOqsg%3D%3D
15. Nakamura H, Ito N, Kotake F, Mizokami Y, Matsuoka T (2000) Tumor-detecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma. J Gastroenterol 35:849-855
16. Vogl TJ, Hammerstingl R, Schwarz W et al. (1996) Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198:881-887 1:CAS:528:DyaK28XhvFChtL8%3D
17. Ward J, Guthrie JA, Scott DJ et al. (2000) Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis. Radiology 216:154-162 1:STN:280:DC%2BD3czksl2ltA%3D%3D
18. Kwak HS, Lee JM, Kim CS (2004) Preoperative detection of hepatocellular carcinoma: Comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Eur Radiol 14:447-457. Epub 2003 Oct 3 10.1007/s00330-003-2070-x
19. Bhartia B, Ward J, Guthrie JA, Robinson PJ (2003) Hepatocellular carcinoma in cirrhotic livers: Double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. Am J Roentgenol 180:577-584
20. Yamamoto H, Yamashita Y, Yoshimatsu S et al. (1995) Hepatocellular carcinoma in cirrhotic livers: Detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 195:106-112 1:STN:280:ByqC1Mbltlc%3D
21. Yu JS, Kim KW, Sung KB, Lee JT, Yoo HS (1997) Small arterial-portal venous shunts: A cause of pseudolesions at hepatic imaging. Radiology 203:737-742
22. Kim T, Choi B, Han J, Chung J, Park J, Han M (1998) Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings. Radiology 208:597-603 1:STN:280:DyaK1czptVSmug%3D%3D
23. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N (2003) Cirrhosis or chronic hepatitis: Evaluation of small (<=2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 226:550-555
24. Yu JS, Kim KW, Kim EK, Lee JT, Yoo HS (1999) Contrast enhancement of small hepatocellular carcinoma: Usefulness of three successive early image acquisitions during multiphase dynamic MR imaging. Am J Roentgenol 173:597-604
25. Reimer P, Balzer T (2003) Ferucarbotran (Resovist): A new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications. Eur Radiol 13:1266-1276. Epub 2002 Nov 1 12764641
26. Vogl TJ, Schwarz W, Blume S et al. (2003) Preoperative evaluation of malignant liver tumors: Comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 13:262-272. Epub 2002 Sep 10 12598989
27. Weishaupt D, Willmann JK, Lutz AM, Marincek B (2004) Resovist for imaging of hepatocellular carcinoma in the cirrhotic liver. Eur Radiol 14:C5-C6